VWM
FLNA

Venturi Wealth Management’s Filana Therapeutics FLNA Stock Holding History

Venturi Wealth Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-500
Closed -$14.7K – 2032
2024
Q3 		$14.7K Hold
500
– – ﹤0.01% 1103
2024
Q2 		$6.17K Hold
500
– – ﹤0.01% 1190
2024
Q1 		$10.1K Hold
500
– – ﹤0.01% 933
2023
Q4 		$11.3K Hold
500
– – ﹤0.01% 852
2023
Q3 		$8.32K Hold
500
– – ﹤0.01% 843
2023
Q2 		$12.3K Hold
500
– – ﹤0.01% 626
2023
Q1 		$12.1K Buy
+500
New +$13.9K ﹤0.01% 687

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Venturi Wealth Management's FLNA Position: Q4 2024 in Review

Venturi Wealth Management sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 500 shares — an estimated $14.7K sold.

Venturi Wealth Management first reported a position in FLNA in Q1 2023 and held it in 7 quarters. The position peaked at $14.7K in Q3 2024. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Venturi Wealth Management reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Venturi Wealth Management sold 500 Filana Therapeutics shares in Q4 2024, an estimated $14.7K.
  • Venturi Wealth Management first reported a position in Filana Therapeutics in Q1 2023 and held it in 7 quarters.
  • Venturi Wealth Management's Filana Therapeutics position peaked at $14.7K in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Venturi Wealth Management's 13F filing for Q4 2024, filed 31 Jan 2025.